KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Costar (CSGP) Research & Development (2016 - 2025)

Costar (CSGP) has disclosed Research & Development for 16 consecutive years, with $109.0 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 31.33% to $109.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $406.0 million through Dec 2025, up 24.54% year-over-year, with the annual reading at $406.0 million for FY2025, 24.54% up from the prior year.
  • Research & Development for Q4 2025 was $109.0 million at Costar, up from $105.4 million in the prior quarter.
  • The five-year high for Research & Development was $109.0 million in Q4 2025, with the low at $46.8 million in Q1 2021.
  • Average Research & Development over 5 years is $71.1 million, with a median of $67.2 million recorded in 2023.
  • The sharpest move saw Research & Development grew 6.21% in 2022, then surged 31.33% in 2025.
  • Over 5 years, Research & Development stood at $52.5 million in 2021, then grew by 11.2% to $58.4 million in 2022, then increased by 20.25% to $70.2 million in 2023, then rose by 18.23% to $83.0 million in 2024, then skyrocketed by 31.33% to $109.0 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $109.0 million, $105.4 million, and $97.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.